These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 33075538)
1. Prospective Sero-epidemiological Evaluation of SARS-CoV-2 among Health Care Workers in a German Secondary Care Hospital. Herzberg J; Vollmer T; Fischer B; Becher H; Becker AK; Sahly H; Honarpisheh H; Guraya SY; Strate T; Knabbe C Int J Infect Dis; 2021 Jan; 102():136-143. PubMed ID: 33075538 [TBL] [Abstract][Full Text] [Related]
2. COVID-19: Hotspot hospital?- seroprevalence of SARS-CoV-2 antibodies in hospital employees in a secondary care hospital network in Germany: Intermediate results of a prospective surveillance study. Hildebrandt A; Hökelekli O; Uflacker L; Rudolf H; Gatermann SG Int J Hyg Environ Health; 2021 Jun; 235():113771. PubMed ID: 34049092 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study. Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ; J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924 [TBL] [Abstract][Full Text] [Related]
4. Antibody response using six different serological assays in a completely PCR-tested community after a coronavirus disease 2019 outbreak-the CoNAN study. Weis S; Scherag A; Baier M; Kiehntopf M; Kamradt T; Kolanos S; Ankert J; Glöckner S; Makarewicz O; Hagel S; Bahrs C; Kimmig A; Proquitté H; Guerra J; Rimek D; Löffler B; Pletz MW; Clin Microbiol Infect; 2021 Mar; 27(3):470.e1-470.e9. PubMed ID: 33221432 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran. Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517 [TBL] [Abstract][Full Text] [Related]
6. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak. Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of IgG antibodies against SARS-CoV-2 among healthcare workers in a tertiary pediatric hospital in Poland. Kasztelewicz B; Janiszewska K; Burzyńska J; Szydłowska E; Migdał M; Dzierżanowska-Fangrat K PLoS One; 2021; 16(4):e0249550. PubMed ID: 33793673 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile. Iruretagoyena M; Vial MR; Spencer-Sandino M; Gaete P; Peters A; Delgado I; Perez I; Calderon C; Porte L; Legarraga P; Anderson A; Aguilera X; Vial P; Weitzel T; Munita JM BMC Infect Dis; 2021 May; 21(1):478. PubMed ID: 34039287 [TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts. Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 antibodies among hospital workers in a German tertiary care center: A sequential follow-up study. Brehm TT; Schwinge D; Lampalzer S; Schlicker V; Küchen J; Thompson M; Ullrich F; Huber S; Schmiedel S; Addo MM; Lütgehetmann M; Knobloch JK; Schulze Zur Wiesch J; Lohse AW Int J Hyg Environ Health; 2021 Mar; 232():113671. PubMed ID: 33338782 [TBL] [Abstract][Full Text] [Related]
11. The seroprevalence of SARS-CoV-2 in a rural southwest community. Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital. Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers. Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave. Barallat J; Fernández-Rivas G; Quirant-Sánchez B; González V; Doladé M; Martinez-Caceres E; Piña M; Matllo J; Estrada O; Blanco I PLoS One; 2020; 15(12):e0244348. PubMed ID: 33370363 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors. Kantele A; Lääveri T; Kareinen L; Pakkanen SH; Blomgren K; Mero S; Patjas A; Virtanen J; Uusitalo R; Lappalainen M; Järvinen A; Kurkela S; Jääskeläinen AJ; Vapalahti O; Sironen T Travel Med Infect Dis; 2021; 39():101949. PubMed ID: 33321195 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic. Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085 [No Abstract] [Full Text] [Related]
17. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV). Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032 [TBL] [Abstract][Full Text] [Related]
18. Seroprevalence study of SARS-CoV-2 antibodies in healthcare workers following the first wave of the COVID-19 pandemic in a tertiary-level hospital in the south of Ireland. Faller E; Wyse A; Barry R; Conlon K; Everard C; Finnegan P; Foran C; Herlihy E; Kerr G; Lapthorne S; McGreal-Bellone A; Morrissey E; O'Sullivan D; O'Sullivan G; Eustace JA; Spillane D; Dempsey C; Benson J; Prentice M; Gallagher J; MacSharry J; Fanning LJ; O'Riordan S; Horgan M; Sadlier C BMJ Open; 2021 Jun; 11(6):e051415. PubMed ID: 34103324 [TBL] [Abstract][Full Text] [Related]
19. [Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?]. Alessi D; Borré S; Barale A; Isabella A; Milano F; Rossi MA; Silano V; Piu N; Cena T; Faggiano F; Epidemiol Prev; 2020; 44(5-6 Suppl 2):200-206. PubMed ID: 33412811 [TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of anti-SARS-CoV-2 IgG among healthcare workers of a large university hospital in Milan, Lombardy, Italy: a cross-sectional study. Lombardi A; Mangioni D; Consonni D; Cariani L; Bono P; Cantù AP; Tiso B; Carugno M; Muscatello A; Lunghi G; Pesatori AC; Riboldi L; Ceriotti F; Bandera A; Gori A BMJ Open; 2021 Feb; 11(2):e047216. PubMed ID: 33619203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]